Min-Ho Kim Lab:Research: Difference between revisions

From OpenWetWare
Jump to navigationJump to search
No edit summary
No edit summary
(One intermediate revision by the same user not shown)
Line 17: Line 17:
|width=1040x class="MainPageBG" style="background-color: #foffff"|
|width=1040x class="MainPageBG" style="background-color: #foffff"|
<div style="padding: right; text-align: left; float: left; padding: .4em .9em .9em ">
<div style="padding: right; text-align: left; float: left; padding: .4em .9em .9em ">
<h3>Research Interests</h3>
<h1>Research Interests</h1>
<font size=3> The major research interests in our laboratory are to (1) understand biological mechanism by which immune cell trafficking contributes to the pathogenesis of chronic inflammatory diseases, (2) apply micro/nano-engineered biomaterials to precisely tune inflammatory environmental cues, and (3) thereby develop clinically feasible therapeutics to promote the resolution of non-healing chronic wounds. Our laboratory utilizes and combines interdisciplinary approaches of immuno-biology, stem cell biology, cellular and tissue engineering, and nano-bioengineering.</font>
<font size=3> The major research interests in our laboratory are to (1) understand biological mechanism by which immune cell trafficking contributes to the pathogenesis of chronic inflammatory diseases, (2) apply micro/nano-engineered biomaterials to precisely tune inflammatory environmental cues, and (3) thereby develop clinically feasible therapeutics to promote the resolution of non-healing chronic wounds. Our laboratory utilizes and combines interdisciplinary approaches of immuno-biology, stem cell biology, cellular and tissue engineering, and nano-bioengineering.</font>
|}
|}
Line 25: Line 25:
|width=1040x class="MainPageBG" style="background-color: #foffff"|
|width=1040x class="MainPageBG" style="background-color: #foffff"|
<div style="padding: right; text-align: left; float: left; padding: .4em .9em .9em ">
<div style="padding: right; text-align: left; float: left; padding: .4em .9em .9em ">
<h3>Current Research Projects</h3>
<h1>Current Research Projects</h1>
<font size=3>
<font size=3>


Line 48: Line 48:
* Prof. Fayez Safadi (NEOMED)
* Prof. Fayez Safadi (NEOMED)
* Prof. Sonping Huang (Kent State)
* Prof. Sonping Huang (Kent State)
* Prof. Deok-Ho Kim (University of Washington)
* Joseph Nayfach (Qteris, Inc.)
* Joseph Nayfach (Qteris, Inc.)
</font>
|}
{| cellspacing="3"
|- valign="top"
|width=1040x class="MainPageBG" style="background-color: #foffff"|
<div style="padding: right; text-align: left; float: left; padding: .4em .9em .9em ">
<h3>Research Support</h3>
<font size=3>
* Farris Family Innovation Award
* Kent State Postdoc Seed Program Award
* Kent State Start-up Fund
</font>
</font>
|}
|}

Revision as of 13:12, 26 November 2014

Home        Lab Members        Publications        Research        Teaching        Contact        News       


Research Interests

The major research interests in our laboratory are to (1) understand biological mechanism by which immune cell trafficking contributes to the pathogenesis of chronic inflammatory diseases, (2) apply micro/nano-engineered biomaterials to precisely tune inflammatory environmental cues, and (3) thereby develop clinically feasible therapeutics to promote the resolution of non-healing chronic wounds. Our laboratory utilizes and combines interdisciplinary approaches of immuno-biology, stem cell biology, cellular and tissue engineering, and nano-bioengineering.

Current Research Projects


  1. Macrophage polarization on therapeutic potential of mesenchymal stem cells (MSCs).
  2. Targeted magnetic nanoparticle thermotherapy for the resolution of biofilm infection in diabetic wounds.
  3. Magnetically responsive injectable microgels for stem cell and tissue engineering.
  4. Nanoengineered biomaterial scaffold for immunomodulation.

Research Collaborators

  • Prof. Chris Malcuit (Kent State)
  • Prof. Chanjoong Kim (Liquid Crystal Institute, Kent State)
  • Prof. Fayez Safadi (NEOMED)
  • Prof. Sonping Huang (Kent State)
  • Joseph Nayfach (Qteris, Inc.)